Summarized by Masters of Longevity from Longevity Docs News.
Alamar and Nightingale will assay low-abundance neurodegeneration proteins in stored UKB samples.
Key Takeaways
- UKB-PRISM will measure hundreds of low-abundance proteins in 80,000 samples.
- Linking protein data to genetics and imaging can reveal early disease signals.
- Cohort findings were observational and have not established diagnostic validity.
